Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...

A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical ...

There is potential for Tregs and amphiregulin to be used in patients receiving cancer therapies to ameliorate immune function.

A team of international researchers led by scientists at City of Hope have demonstrated a way to boost thymic function after ...

As we age, our immune systems undergo a gradual decline in function, but there are things we can do now to help keep them ...

Thymalfasin is under clinical development by SciClone Pharmaceuticals and currently in Phase II for Thymic Carcinoma. According to GlobalData, Phase II drugs for Thymic Carcinoma does not have ...

TSLP靶点是时下最火热的医药赛道之一，GSK不惜为其豪掷10亿美元；NewCo是如今最火热的医药融资方式，几乎所有药企都希望能够通过NewCo破局。当最火热的赛道，碰上最火热的融资方式，两者又会擦出怎样的火花呢？和铂医药就完成了一项如此引人瞩目的交易。 1月10日，和铂医药与科伦博泰联合宣布，与Windward Bio AG（以下简称“Windward Bio”）完成了一项资本交易。根据协议，W ...